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Abstract
Transanal total mesorectal excision (TaTME) is widely performed for the resection of rectal cancer around the world. 
However, due to lower body mass index and a lack of necessity, TaTMEs have not been accepted in East Asia as generally 
as in Western countries. In East Asia, conventional laparoscopic surgeries have been performed with lower rates of open 
conversions and robotic surgery has been considered as an acceptable option for patients with narrow pelvis. This review 
article discusses TaTMEs from an East Asian perspective. 
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INTRODUCTION
The evaluation and management of rectal cancer has evolved remarkably over the last few decades since 
Heald et al.[1] proposed and reported on total mesorectal excisions for rectal cancer in the reduction of 
local recurrences. Total mesorectal excision (TME) became the gold standard for curative resection from 
the standpoint of control and survival. In addition to increased anatomical knowledge, surgical instruments 
have also improved. In the early 1990s, laparoscopic surgery was introduced and gradually used in colon 
and rectal cancer treatments. Since several multicenter randomized trials reported potential short-term 
benefits with oncological outcomes comparable to open surgeries, laparoscopic TMEs were adopted for 
rectal cancer[2,3]. However, several prospective trials failed to prove the non-inferiority of laparoscopy, citing 
several reasons[4,5]. Most of the reasons were attributed to the difficulty in ensuring a sufficient surgical 
field in a narrow space. The three most common reasons for open conversions in the Colorectal Cancer 
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Laparoscopic or Open Resection (COLOR) II trial were a narrow pelvis (22%), obesity (10%), and tumor 
fixation (9%)[6]. 
To overcome the technical difficulties associated with laparoscopic TMEs, which resulted in poor 
visualization of the mesorectal planes and difficulty introducing instruments, the concept of a “bottom-
up” alternative technique (from the distal to the proximal mesorectal plane), was proposed with the first 
transanal TME (TaTME) procedure performed in patients with rectal cancer in 2010 by Sylla et al.[7]. 
Before TaTME was introduced, new minimally invasive devices and innovations using the Natural Orifice 
Transluminal Endoscopic Surgery technique and the Transanal Endoscopic Microsurgery method were 
initiated, which made the concept possible[8]. The transabdominal transanal proctosigmoidectomy (TATA), 
which is similar to TaTMEs and was developed by Marks[9] in 1984, introduced the bottom-up technique, 
in contrast to the traditional top-down technique typically used in abdominal procedures.
In this review article, we focus on current and future East Asian perspectives. Since severely obese rectal 
cancer patients are still rare in East Asian countries, there is less need for TaTMEs compared to Western 
countries. The low rate of high body mass index (BMI) may be one of the reasons for the low conversion 
rate of laparoscopic surgery for rectal cancer and even for mid and low rectal cancers after neoadjuvant 
chemoradiotherapy compared to the high conversion rates in the COLOR II (16%) and the American 
College of Surgeons Oncology Group (ACOSOG) Z6051 (11.3%) trials.
ROBOTIC TME: EFFORTS TO OVERCOME THE DIFFICULTIES OF LAPAROSCOPIC TMES
Technical limitations exist with the laparoscopic approach, especially during the distal transection of the 
rectum due to limited visibility and working restrictions associated with the confined space of a narrow 
pelvis[10]. Recently, robotic surgery has been proposed as a solution to this problem. Although there is no 
concrete evidence that robotic surgery has an advantage in difficult cases, robotic-assisted surgery was 
introduced to address the limitations of laparoscopy, and gained acceptance due to improved visualization, 
lower conversion rates, better TME quality with lower positive circumferential resection margin (CRM) 
rates, and earlier recovery of genitourinary functions[11-13]. 
According to our experience at Severance Yonsei University Hospital in South Korea, the robotic group 
showed a lower conversion rate (0% vs. 7.1%, P = 0.003) when patients with upper rectal tumors were 
enrolled[14]. In addition, when we compared patients who only underwent robotic surgery vs. laparoscopic 
surgery with coloanal anastomosis, with or without intersphincteric resections, including patients with 
mean tumor heights of 5.5 cm and 4.4 cm from the anal verge, the conversion rates were 2.1% vs. 16.2%, 
P = 0.020, respectively[15]. The robotic groups showed better results in terms of open conversion rates. 
In addition, when we compared patients who had robotic TMEs according to pelvimetry, there were no 
differencess among easy, moderate, and difficult groups in terms of operative times, which were used as 
surrogate markers for TME difficulty[16]. 
In the Robotic vs. Laparoscopic Resection for Rectal Cancer (ROLARR) trial[17], the overall conversion 
rates were 12.2% and 8.1% for laparoscopic and robotic TME surgeries, respectively. However, 27.8% of 
obese patients undergoing laparoscopic TMEs and 18.9% in the robotic TME group required conversions. 
Although the robotic TME group showed better results than the laparoscopic TME group, the conversion 
rates were still high. In addition to high BMI, lower rectal cancers and the male gender were associated 
with increased conversion rates. Moreover, accurate identification of the distal margin and the application 
of the endoscope at right angles to the rectum can be challenging in a narrow pelvis.
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TATME: EFFORTS TO OVERCOME THE DIFFICULTY OF LAPAROSCOPIC TMES
Risk factors in the ROLARR trial could be diminished using TaTMEs as constraints and challenges 
posed by anatomical features are minimized when approached from below. TaTMEs also showed lower 
conversion rates. Penna et al.[18] reported conversion rates from laparoscopic to open or transanal as 6.3% 
within the TaTME registry. Veltcamp Helbac et al.[19] reported a conversion rate of 5% for 80 TaTME cases. 
Moreover, Lacy et al.[20] reported no conversions in 140 cases. TaTME procedures overcome difficulties 
frequently encountered in trans-abdominal rectal transections and anastomosis-stapling techniques such 
as narrow pelvic anatomy, oblique stapling angles, rectal-tearing secondary to vigorous manipulation, and 
multiple staple firings.
Robotic surgery and transanal surgery have been developed to overcome some of the limitations of 
conventional laparoscopic surgery for rectal cancer. However, there are only a few studies comparing 
robotic and TaTME[21-23]. Those studies showed comparable results for robotic TME and TaTME. Among 
the studies, Lee et al.[21] compared, out of a total of 730 patients (277 TaTME and 453 robotic TME 
patients), matched groups of 226 TaTME and 370 robotic TME patients. The mean tumor height from the 
anal verge was 5.6 cm, and 70% received preoperative radiotherapy. There were no differences in TME 
specimen quality and CRM.
However, the evidence on TaTME is still lacking in many aspects with many still unanswered questions. 
Retrospective studies and meta-analysis showed that TaTME seems to achieve comparable technical success 
with acceptable oncologic and perioperative outcomes in comparison with laparoscopic TME[24]. However, 
there is no multicenter randomized controlled trial at present. The COLOR III trial, which compares 
TaTME and laparoscopic TME, is currently in the recruitment phase. 
PREVIOUS EAST ASIAN STUDIES ON TATME
There have been a few reports describing the use of TaTMEs in Asian patients. One study from Taiwan[25] 
compared 50 patients with middle or lower rectal cancer and post-neoadjuvant chemoradiotherapy (nCRT) 
who underwent TaTMEs using 100 matched control cohorts who received conventional laparoscopic rectal 
surgeries. Seventy-six percent of the patients were male with a mean BMI of 24.2 kg/m2 and had low (< 7 cm) 
tumor heights. There was only one conversion. Another prospective, single-arm phase II trial from Korea[26] 
enrolled 49 patients (65.3% male, a mean BMI of 23.3 kg/m2, and a mean tumor height of 6.3 cm) with their 
rectal cancers located 3-12 cm from the anal verge and no conversions to open surgery. A study from Hong 
Kong[27] compared a TaTME group (n = 40) to a robotic group (n = 80) using propensity score matching. In 
the TaTME group, 72.5% of the patients were male and the median tumor height was 5.0 cm. There was a 
5% conversion rate. All three of these studies concluded that TaTMEs were safe and feasible with acceptable 
results based on the perioperative and pathologic outcomes. Although conversion rates were higher than 
in the Comparison of Open vs. Laparoscopic Surgery for mid or low Rectal Cancer after Neoadjuvant 
Chemoradiotherapy (COREAN) trial, they are quite low compared to previous laparoscopic TME results. 
Recently, studies by Chinese surgeons using TaTMEs have begun. After a preliminary study[28] with 20 
patients that confirmed the safety and feasibility of the procedure, they began randomized controlled trial 
(RCT) enrollment in June 2019 to compare laparoscopic TMEs with TaTMEs (NCT03413930). They will 
only include patients with middle or lower rectal cancers similar to the East Asian studies. 
ARE TATMES NECESSARY FOR EAST ASIA?
Presently, TaTMEs in East Asia are not as popular as in Western countries since few patients have BMIs 
above 30 kg/m2. In females, even for those with lower rectal cancer, conventional laparoscopic TMEs can 
be accomplished without conversions. Additionally, robotic systems are used more frequently only in high 
volume centers. Another issue is the cost which patients should pay, especially in Korea where a two-team 
approach is not feasible due to the insurance system.
TATMES ARE NEEDED FOR EAST ASIA!
Even in East Asian patients, conventional laparoscopic TMEs are difficult for those with narrow pelvis. 
Several studies in Asia have found that a deep, narrow pelvis was an independent factor for intraoperative 
and postoperative outcomes[29-32]. Most studies using preoperative computed tomography and magnetic 
resonance pelvimetry have shown that the bones of the pelvis - the depth and length of sacrum, the pelvic 
inlet, and the pelvic outlet - are independent predictors for the operative times, which have been used 
as surrogate markers for determining TME difficulty[29,30,32]. Limited pelvic space impacts the quality of 
resected TME specimens[30,33]. Identifying the East Asian patients having normal BMIs with narrow pelvis 
before surgery has been beneficial for deciding if TaTMEs should be used. Often, we perform a transanal 
approach after transabdominal TMEs to ease resection and easily obtain quality resected TME specimens. 
A study which utilized TaTMEs in challenging patients included a total of 12 patients (9 males and 3 
females): 1 obese patient, 7 with large tumors, and 8 with threatened mesorectal fascias (four patients had 
multiple indications)[34]. The median tumor height was 5.5 cm from the anal verge, and all patients received 
preoperative chemoradiotherapy. There were no intraoperative complications. Only 1 patient required 
conversion to open surgery for ureterocystostomy after resection. Larger TaTME studies involving Asian 
patients are necessary to promote TaTMEs.
A CONCRETE INDICATION IS NECESSARY
Since TaTME has only just recently been introduced, the criteria of surgical candidates best suited for 
TaTME treatments are still evolving[35]. A recent consensus statement was published which listed the 
following indications for TaTME: (1) male gender; (2) narrow and/or deep pelvis; (3) visceral obesity 
and/or a BMI > 30 kg/m2; (4) prostatic hypertrophy; (5) tumor height < 12 cm from the anal verge; (6) 
tumor diameter > 4 cm; (7) distortion of tissue planes secondary to neoadjuvant radiotherapy; and (8) an 
impalpable, lower primary tumor requiring accurate placement of the distal resection margin[36]. However, 
we believe that TaTMEs should be used in challenging cases to replace the transabdominal approach. In 
East Asia, challenging cases imply that patients are males with deep and narrow pelvis after preoperative 
chemotherapy. While TaTME was developed to assist in challenging middle to lower rectal cancer cases, 
its essential purpose should be initially adopted. In East Asia, a more concrete indication distinct from 
laparoscopic and robotic TMEs is required for transition to TaTMEs.
Moreover, the application of TaTMEs was recently extended to include benign tumor excisions, endopelvic 
surgeries, and pelvic exenterative surgeries[37]. In situations where robotic systems are used in high-volume 
centers, robotic TaTMEs can be a useful new technique as various robotic systems are developed.
PROBLEMS IN ADOPTING TATME IN EAST ASIA
The other issues for TaTME are the learning curve and training. The transition from laparoscopic TME 
to robotic TME is straightforward as the approach is the same. However, the technical complexity and 
unusual anatomy have led to the occurrence of rare complications such as urethral injury[38]. In terms of 
oncological outcome, Larsen et al.[39] reported 9.5% local recurrence, which led to a nationwide in norway 
halt of TaTME and thorough investigation. They suggested that the increase of local recurrences after 
TaTMEs might, to some extent, be due to the learning curve, which is inevitable in the introduction of a 
complex procedure. In addition, only a few centers in East Asia have accumulated much experience and 
have good results on TaTME. To adopt TaTME safely, a training strategy such as the detailed framework for 
a structured TaTME training curriculum proposed by the International TaTME Educational Collaborative 
Group is necessary[40]. 
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CONCLUSION
TaTMEs are potential alternatives for East Asian male patients with rectal cancer who have deep and 
narrow pelvis. Many RCT and prospective studies (especially the RCT in China) are underway that could 
provide concrete indications for the usefulness and necessity of TaTMEs[41] in East Asia. To further promote 
TaTMEs in East Asia, further research with East Asian populations and training strategy are necessary. 
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